Evidence map›Paper›PMID 40269932›Full record

ArticleJournal of nanobiotechnology2025

Indacenodithienothiophene-based A-D-A-type phototheranostics for immuno-phototherapy.

Yangtian Ye, Shaojing Zhao, E Pang, Yuanyu Tang, Pan Zhu, Wenjie Gao, Qingxu Diao, Jie Yu, Jie Zeng, Minhuan Lan and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nanobiotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yangtian YeDepartment of Breast and Thyroid Gland Surgery, Hunan Provincial Maternal And Child Health Care Hospital, Changsha, Hunan, 410008, China.
Shaojing ZhaoCollege of Chemistry and Chemical Engineering, Central South University, Changsha, Hunan, 410083, China.
E PangCollege of Chemistry and Chemical Engineering, Central South University, Changsha, Hunan, 410083, China.
Yuanyu TangCollege of Chemistry and Chemical Engineering, Central South University, Changsha, Hunan, 410083, China.
Pan ZhuCollege of Chemistry and Chemical Engineering, Central South University, Changsha, Hunan, 410083, China.
Wenjie GaoDepartment of General Surgery, Sir Run Run Hospital of Nanjing Medical University, Nanjing, Jiangsu, 211166, China.
Qingxu DiaoDepartment of Breast and Thyroid Gland Surgery, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan, 410005, China.
Jie YuDepartment of Breast and Thyroid Gland Surgery, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan, 410005, China.
Jie ZengDepartment of Breast and Thyroid Gland Surgery, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan, 410005, China. zengjie227@hunnu.edu.cn.
Minhuan LanCollege of Chemistry and Chemical Engineering, Central South University, Changsha, Hunan, 410083, China. minhuanlan@csu.edu.cn.
Jianing YiDepartment of Breast and Thyroid Gland Surgery, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan, 410005, China. yijianing@hunnu.edu.cn.

Funding

National Natural Science Foundation of China Nos. 62375289Natural Science Foundation of Hunan Province Nos. 2024JJ9285Scientific Research Project of Hunan Provincial Department of Education Nos. 22B0081
6 · The paper itself

Abstract

The development of phototherapeutics with high photothermal conversion efficiency (PCE) and strong ability to generate reactive oxygen species under single near-infrared (NIR) laser irradiation for immuno-phototherapy applications remains a significant challenge. Herein, we optimally selected the molecule IT-4 F with an acceptor-donor-acceptor (A-D-A) strucssture to prepare water-dispersible nanoparticles (NPs) by assembly with DSPE-PEG-NH

Indexed as

ImmunotherapyPhototherapyTheranostic NanomedicineThiophenesAnimalsCell Line, TumorFemaleHumansMiceMice, Inbred BALB CNanoparticlesPhotochemotherapyPhotosensitizing AgentsPhotothermal TherapyReactive Oxygen SpeciesSinglet OxygenPhotosensitizing AgentsReactive Oxygen SpeciesSinglet OxygenThiophenesHuman breast cancerImmunogenic cell deathPANoptosisPhotodynamic therapyPhotothermal therapy

Identifiers

PMID40269932
PMCPMC12016427

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.